R. Dewey

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK

G. Wilkinson, D. Klatzmann, M. Castro, 2000, Gene Therapy.

FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors

P. Lowenstein, A. Fontana, P. Lowenstein, 1998, Gene Therapy.

Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas.

D. Klatzmann, P. Lowenstein, M. Castro, 2000, The Journal of clinical endocrinology and metabolism.

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

H. Lassmann, D. Klatzmann, P. Lowenstein, 1999, Nature Medicine.

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.

P. Lowenstein, A. Fontana, M. Castro, 1999, The Journal of general virology.